Skip Navigation

European Heart Journal 1995 16(Supplement F):4-6; doi:10.1093/eurheartj/16.suppl_F.4
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Packer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Packer, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure

M. Packer

From the Division of Circulatory Physiology and Center for Heart Failure Research, Columbia University, College of Physicians and Surgeons New York NY U.SA.

Correspondence Milton Packer, MD, Division of Circulatory Physiology, Columbia-Presbyterian Medical Center, 630 West 168th Street, New York, NY 10032, U.S.A.

During the last 20 years, physicians have generally regarded heart failure as a haemodynamic disorder in an attempt to explain patients' symptoms and disability. This model led to the widespread evaluation of peripheral vasodilators and the development of novel positive inotropic agents, but long-term use of these drugs failed to improve symptoms and was frequently accompanied by an increase in the risk of death. These clinical observations raised concerns about the validity of the haemodynamic hypothesis and led to the development of alternative models of heart failure—most importantly, the neurohormonal hypothesis. According to the neurohormonal model, heart failure develops and progresses because endogenous neurohormonal systems that are activated by the initial injury to the heart exert a deleterious effect on the circulation. Recognition of the importance of neurohormonal activation has led to the intense interest in the use of neurohormonal antagonists—converting-enzyme inhibitors and beta-adrenergic blockers–in the treatment of chronic heart failure. The results of randomized clinical trials with a variety of neurohormonal antagonists have been encouraging, and widespread acceptance of these drugs is expected to lead to clinical benefits for many patients.

Key Words: Heart failure • neurohormonal activation • ACE inhibitors • beta-blockers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. Francis, S.-G. Wei, R. M. Weiss, and R. B. Felder
Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2138 - H2146.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
M. M. Multani, R. S. Krombach, A. T. Goldberg, M. K. King, J. W. Hendrick, J. A. Sample, S. C. Baicu, C. Joffs, M. deGasparo, and F. G. Spinale
Myocardial Bradykinin Following Acute Angiotensin-Converting Enzyme Inhibition, AT1 Receptor Blockade, or Combined Inhibition in Congestive Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 369 - 376.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.